Outsourced Pharma App Notes & Case Studies
-
Reliability Assessments And Benchmarking In Life Sciences
11/7/2023
Gain insight into how a prominent medical device manufacturer observed a significant improvement in its plant-wide OSHA recordable rate and cost of goods savings of over $100,000/year in just one year.
-
Re-Engineering A Complex Process For FDA Compliance
8/21/2024
Discover the strategies that helped a company navigate a complex and shifting regulatory landscape to rapidly re-engineer a COVID-19 vaccine manufacturing process for FDA compliance.
-
Overcome Common Pre-Filled Syringe Challenges Through Partnership
5/23/2025
The pre-filled syringe space is one of the fastest growing pharma sectors, offering greater patient safety and lower manufacturing costs. But pre-filled doesn’t translate to easily filled; there are particular obstacles to overcome.
-
Alkaline Stability Of Modern Protein A Chromatography Resins
7/12/2023
Explore results from a resin lifetime study with over 150 cycles, using clarified cell harvest in every cycle, which has been performed to evaluate the alkaline stability of three protein A resins.
-
Innovative ASD Technology Improves Abandoned Cancer Medication
3/1/2024
Review this case to learn how one solid dispersion technology lowered patients' pill burdens and demonstrated an improved therapeutic response for Galeterone.
-
Advancements In GLP-1 Analog Formulation: Overcoming Challenges
2/3/2025
Oral GLP-1 formulations represent a groundbreaking advance in obesity treatment to offer improved patient comfort and adherence while expanding the therapeutic market.
-
Bulk Filling Of Drug Substance | Accurate Aliquoting
4/24/2024
Bulk filling drug substances in traditional facilities is often a lengthy, manual process where operators are relied upon to adjust pump controls to achieve accurate filling. This method, spanning multiple shifts, increases process risk through errors that can compromise accuracy.
-
Integrated Services For Cell Line Preparation And Storage
10/8/2024
Explore a comprehensive suite of services for the manufacture, characterization, and storage of cell banks as well as the advantages of working with an experienced partner.
-
A Transient Cell Line To Produce rAAV With Low-Level hcDNA Encapsidation
1/15/2025
Discover the ability of a novel HEK293 suspension cell line for efficient and scalable rAAV production across various serotypes with low encapsidated host cell DNA levels.
-
The Evolution Of AAV Production: Scaling Through Nature Instead Of Brute Force
5/28/2025
This study evaluates the performance and productivity of VintaProcess in addressing the persistent manufacturing challenges in AAV gene therapy production.